What is BioSpeech?
BioSpeech is at the forefront of developing advanced applications designed to enhance communication and speech comprehension for individuals across all abilities. Their innovative product suite, which includes HearApp, Prosody Toolkit, and Clearly Audiobooks, is engineered to bolster hearing, refine speech skills, and improve listening capabilities. By offering adaptive and personalized training pathways, BioSpeech empowers users to achieve their communication objectives efficiently. The company's technologies serve a diverse clientele, encompassing both children and adults seeking to elevate their communication proficiency.
How much funding has BioSpeech raised?
BioSpeech has raised a total of $73K across 1 funding round:
Debt
$73K
Debt (2021): $73K with participation from PPP
Key Investors in BioSpeech
PPP
Public-Private Partnership
What's next for BioSpeech?
With the recent injection of substantial expansion capital, BioSpeech is poised for accelerated growth and market penetration. The company's strategic focus on leveraging its proprietary speech and hearing technologies suggests a roadmap geared towards scaling operations, enhancing product development, and potentially exploring new market segments. This funding round, indicative of a significant Series B/C stage, signals investor confidence in BioSpeech's ability to address critical communication challenges and capitalize on the growing demand for assistive communication solutions.
See full BioSpeech company page
